Epidermodysplasia verruciformis in an HIV-infected man: A case report and review of the literature

Topics in Antiviral Medicine

Volumn 20, Issue 5, 2012, Pages 173-179

  Kaushal, Amit ^a   Silver, Shane ^a   Kasper, Ken ^a   Severini, Alberto ^a   Hamza, Sate ^a   Keynan, Yoav ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878780041     PISSN: 21615861     EISSN: 21615853     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Lewandowsky F, Lutz W. Archives of dermatology and syphilology. Berlin: 1922:141(193).
2. Tanigaki T, Kanda R, Sato K. Epidermodysplasia verruciformis (L-L, 1922) in a patient with systemic lupus erythematosus. Arch Dermatol Res. 1986;278(3):247-248.
3. Barr BB, Benton EC, McLaren K, et al. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet. 1989;2(8656):224-225.
4. Gross G, Ellinger K, Roussaki A, et al. Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol. 1988;91(1):43-48.
5. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol. 1995;131(11):1312-1318.
6. Sehgal VN, Luthra A, Bajaj P. Epidermodysplasia verruciformis: 14 members of a pedigree with an intriguing squamous cell carcinoma transformation. Int J Dermatol. 2002;41(8):500-503.
7. Orth G. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp. 1986;120):157-174.
8. Lutzner MA. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer. 1978;65(2):169-182.
9. Androphy EJ, Dvoretzky I, Lowy DR. Xlinked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol. 1985;121(7):864-868.
10. Rajagopalan K, Bahru J, Loo DS, et al. Familial epidermodysplasia verruciformis of Lewandowsky and Lutz. Arch Dermatol. 1972;105(1):73-78.
11. Ramoz N, Rueda LA, Bouadjar B, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet. 2002;32(4):579-581.
12. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22(22):4673-4680.
13. Krogh A, Larsson B, von HG, et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001;305(3):567-580.
14. Carre D, Dompmartin A, Verdon R, et al. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol. 2003;42(4):296-300.
15. Akgul B, Kose O, Safali M, et al. A distinct variant of Epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations. J Dermatol Sci. 2007;46(3):214-216.
16. Azzimonti B, Mondini M, De AM, et al. CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch Dermatol. 2005;141(10):1323-1325.
17. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol. 2002;138(5):649-654.
18. Lane JE, Bowman PH, Cohen DJ. Epidermodysplasia verruciformis. South Med J. 2003;96(6):613-615.
19. Rogers HD, Macgregor JL, Nord KM, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2009;60(2):315-320.
20. Berkhout RJ, Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol. 1995;33(3):690-695.
21. Sun XW, Ellerbrock TV, Lungu O, et al. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol. 1995;85(5 Pt 1): 680-686.
22. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97(8):577-586.
23. de Pokomandy A, Rouleau D, Ghattas G, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis. 2009;199(7):965-973.
24. Cameron JE, Hagensee ME. Oral HPV complications in HIV-infected patients. Curr HIV/AIDS Rep. 2008;5(3):126-131.
25. Adler DH. The impact of HAART on HPVrelated cervical disease. Curr HIV Res. 2010;8(7):493-497.
26. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol. 2000;61(3):289-297.
27. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis. 2002;15(2):101-114.
28. Iftner A, Klug SJ, Garbe C, et al. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res. 2003;63(21):7515-7519.
29. Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol. 2004;193(1):35-44.
30. Munoz N, Bosch FX, de SS, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-527.
31. Kreuter A, Brockmeyer NH, Weissenborn SJ, et al. Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. J Invest Dermatol. 2008;128(9):2316-2324.
32. Favre M, Majewski S, De JN, et al. A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis. J Invest Dermatol. 1998;111(2):333-336.
33. Mermet I, Guerrini JS, Cairey-Remonnay S, et al. Cervical intraepithelial neoplasia associated with epidermodysplasia verruciformis HPV in an HIV-infected patient: a manifestation of immune restoration syndrome. Eur J Dermatol. 2007;17(2):149-152.
34. Orth G. Epidermodysplasia verruciformis. In: Howley P, Salzman N, eds. The Papillomaviruses. New York: Plenum Press; 1987:199-243.
35. Barzegar C, Paul C, Saiag P, et al. Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection. Br J Dermatol. 1998;139(1):122-127.
36. Jacobelli S, Laude H, Carlotti A, et al. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy. Arch Dermatol. 2011;147(5):590-596.
37. Davison SC, Francis N, McLean K, et al. Epidermodysplasia verruciformis-like eruption associated with HIV infection. Clin Exp Dermatol. 2004;29(3):311-312.
38. Burger B, Kind F, Spoerri I, et al. HIVpositive child with epidermodysplasia verruciformis-like lesions and homozygous mutation in TMC6. AIDS. 2010;24(17):2758-2760.
39. Prose NS, von Knebel-Doeberitz C, Miller S, Milburn PB, Heilman E. Widespread flat warts associated with human papillomavirus type 5: a cutaneous manifestation of human immunodeficiency virus infection. J Am Acad Dermatol. 1990;23(5 Pt 2):978-981.
40. Berger TG, Sawchuk WS, Leonardi C, et al. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease. Br J Dermatol. 1991;124(1):79-83.
41. Haas N, Fuchs PG, Hermes B, et al. Remission of epidermodysplasia verruciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient. Br J Dermatol. 2001;145(4):669-670.
42. Trauner MA, Ruben BS, Hatcher SL, et al. Groin eruption in an HIV-positive man: epidermodysplasia verruciformis (EDV). Arch Dermatol. 2002;138(4):527-532.
43. Hu W, Nuovo G, Willen M, et al. Epidermodysplasia verruciformis in two half brothers with HIV infection. J Cutan Med Surg. 2004;8(5):357-360.
44. Bonamigo R, Maldonado G, Londero RM, et al. Epidermodysplasia verruciformislike disorder in a teenager with HIV and HCV infections. Pediatr Dermatol. 2007;24(4):456-457.
45. Hultgren TL, Srinivasan SK, DiMaio DJ. Epidermodysplasia verruciformis occurring in a patient with human immunodeficiency virus: a case report. Cutis. 2007;79(4):307-311.
46. Chen P, Jr., Kamino H, Walters RF, et al. Epidermodysplasia verruciformis in the setting of HIV infection. Dermatol Online J. 2008;14(10):1.
47. Berk DR, Bruckner AL, Lu D. Epidermodysplasia verruciform-like lesions in an HIV patient. Dermatol Online J. 2009;15(1):1.